Long-sustaining response in a patient with non-resectable, distant recurrence of glioblastoma multiforme treated by interstitial photodynamic therapy using 5-ALA: Case report

Journal of Neuro-Oncology

Volumn 87, Issue 1, 2008, Pages 103-109

  Stummer, Walter ^a   Beck, Tobias ^b   Beyer, Wolfgang ^b   Mehrkens, Jan Hendrik ^b   Obermeier, Andreas ^b   Etminan, Nima ^a   Stepp, Herbert ^b   Tonn, Jörg Christian ^b   Baumgartner, Reinhold ^b   Herms, Jochen ^b   Kreth, Friedrich Wilhelm ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

5 aminolevulinic acid; ALA; Glioblastoma; Interstitial; Local therapy; Malignant glioma; Photodynamic therapy; Porphyrins; Protoporphyrin IX; Stereotactic; Stereotactic surgery

Indexed keywords

5 AMINOLEVULINATE SYNTHASE; DEXAMETHASONE; ERYTHROPOIETIN; HYDROXYUREA; IMATINIB; LOMUSTINE; NIMUSTINE; PROCARBAZINE; TEMOZOLOMIDE; TENIPOSIDE; VINCRISTINE;

ADULT; ANEMIA; ARTICLE; BONE MARROW SUPPRESSION; BRAIN EDEMA; CASE REPORT; CLINICAL EFFECTIVENESS; DISEASE COURSE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GLIOBLASTOMA; GRAND MAL SEIZURE; HUMAN; KARNOFSKY PERFORMANCE STATUS; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PHOTODYNAMIC THERAPY; RADIATION DOSE; STEREOTAXIC SURGERY; TREATMENT RESPONSE; TUMOR VOLUME;

ADULT; AMINOLEVULINIC ACID; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; GLIOBLASTOMA; HUMANS; MAGNETIC RESONANCE IMAGING; NEOPLASM RECURRENCE, LOCAL; PHOTOSENSITIZING AGENTS; PHOTOTHERAPY; TIME;

EID: 38649127265     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-007-9497-x     Document Type: Article

References (29)

1. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO; European Organisation for Research, Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996
2. Brem H, Piantadosi S, Burger PC, Walker M, Selker R, Vick NA, Black K, Sisti M, Brem S, Mohr G et al (1995) Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The polymer-brain tumor treatment group. Lancet 345:1008-1012
3. Yung WK, Albright RE, Olson J, Fredericks R, Fink K, Prados MD, Brada M, Spence A, Hohl RJ, Shapiro W, Glantz M, Greenberg H, Selker RG, Vick NA, Rampling R, Friedman H, Phillips P, Bruner J, Yue N, Osoba D, Zaknoen S, Levin VA (2000) A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse. Br J Cancer 83:588-593
4. Kunwar S, Prados MD, Chang SM, Berger MS, Lang FF, Piepmeier JM, Sampson JH, Ram Z, Gutin PH, Gibbons RD, Aldape KD, Croteau DJ, Sherman JW, Puri RK; Cintredekin Besudotox Intraparenchymal Study Group (2007) Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: A report by the cintredekin besudotox intraparenchymal study group. J Clin Oncol 25:837-844
5. Rainov NG (2000) A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. Hum Gene Ther 11:2389-2401
6. Stummer W, Stocker S, Novotny A, Heimann A, Sauer O, Kempski O, Plesnila N, Wietzorrek J, Reulen HJ (1998) In vitro and in vivo porphyrin accumulation by C6 glioma cells after exposure to 5-aminolevulinic acid. J Photochem Photobiol B 45:160-169
7. Stummer W, Stocker S, Wagner S, Stepp H, Fritsch C, Goetz C, Goetz AE, Kiefmann R, Reulen HJ (1998) Intraoperative detection of malignant gliomas by 5-aminolevulinic acid induced porphyrin fluorescence. Neurosurgery 42:518-525
8. Stummer W, Novotny A, Stepp H, Goetz C, Bise K, Reulen HJ (2000) Fluorescence guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: As prospective study in 52 consecutive patients. J Neurosurg 93:1003-1013
9. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: A randomised controlled multicentre phase III trial. Lancet Oncol 7:392-401
10. Zelenkov P, Baumgartner R, Bise K, Heide M, Meier R, Stocker S, Sroka R, Goldbrunner R, Stummer W (2007) Acute morphological sequelae of photodynamic therapy with 5-aminolevulinic acid in the C6 spheroid model. J Neuro Oncol 82:49-60
11. Karmakar S, Banik NL, Patel SJ, Ray SK (2007) 5-Aminolevulinic acid-based photodynamic therapy suppressed survival factors and activated proteases for apoptosis in human glioblastoma U87MG cells. Neurosci Lett 415:242-247
12. Inoue H, Kajimoto Y, Shibata MA, Miyoshi N, Ogawa N, Miyatake S, Otsuki Y, Kuroiwa T (2007) Massive apoptotic cell death of human glioma cells via a mitochondrial pathway following 5-aminolevulinic acid-mediated photodynamic therapy. J Neurooncol 83:223-231
13. Hirschberg H, Sun CH, Krasieva T, Madsen SJ (2006) Effects of ALA-mediated photodynamic therapy on the invasiveness of human glioma cells. Lasers Surg Med 38:939-945
14. Angell-Petersen E, Spetalen S, Madsen SJ, Sun CH, Peng Q, Carper SW, Sioud M, Hirschberg H (2006) Influence of light fluence rate on the effects of photodynamic therapy in an orthotopic rat glioma model. J Neurosurg 104:109-117
15. Olzowy B, Hundt CS, Stocker S, Bise K, Reulen HJ, Stummer W (2002) Photoirradiation therapy of experimental malignant glioma with 5-aminolevulinic acid. J Neurosurg 97:970-976
16. Beck TJ, Kreth FW, Beyer W, Mehrkens JH, Obermeier A, Stepp H, Stummer W, Baumgartner R (2007) Interstitial photodynamic therapy of nonresectable malignant glioma recurrences using 5-aminolevulinic acid induced protoporphyrin IX. Lasers Surg Med 39:386-393
17. Madsen S, Hirschberg H (2006) Photodynamic therapy and detection of high-grade gliomas. J Environ Pathol Toxicol Oncol 25:453-466
18. Powers SK, Cush SS, Walstad DL, Kwock L (1991) Stereotaxic intratumoral photodynamic therapy for recurrent malignant brain-tumors. Neurosurgery 29:688-696
19. Krishnamurthy S, Powers SK, Witmer P, Brown T (2000) Optimal light dose for interstitial photodynamic therapy in treatment for malignant brain tumors. Lasers Surg Med 27:224-234
20. Schmidt MH, Meyer GA, Reichert KW, Cheng J, Krouwer HG, Ozker K, Whelan HT (2004) Evaluation of photodynamic therapy near functional brain tissue in patients with recurrent brain tumors. J Neuro Oncol 67:201-207
21. Hebeda KM, Kamphorst W, Sterenborg HJCM, Wolbers JG (1998) Damage to tumour and brain by interstitial photodynamic therapy in the 9L rat tumour model comparing intravenous and intratumoral administration of the photosensitiser. Acta Neurochir 140:495-501
22. Chen Q, Chopp M, Madigan L, Dereski MO, Hetzel FW (1996) Damage threshold of normal rat brain in photodynamic therapy. Photochem Photobiol 64:163-167
23. Dereski MO, Chopp M, Chen Q, Hetzel FW (1989) Normal braintissue response to photodynamic therapy-histology, vascular-permeability and specific-gravity. Photochem Photobiol 50:653-657
24. Whelan HT, Schmidt MH, Segura AD, McAuliffe TL, Bajic DM, Murray KJ, Moulder JE, Strother DR, Thomas JP, Meyer GA (1993) The role of photodynamic therapy in posterior fossa brain tumors. A preclinical study in a canine glioma model. J Neurosurgery 79:562-568
25. Stummer W, Gotz C, Hassan A, Heimann A, Kempski O (1993) Kinetics of Photofrin II in perifocal brain edema. Neurosurgery 33:1075-1081
26. Stummer W, Hassan A, Kempski O, Goetz C (1996) Photodynamic therapy within edematous brain tissue: Considerations on sensitizer dose and time point of laser irradiation. J Photochem Photobiol B 36:179-181
27. van Duijnhoven FH, Aalbers RI, Rovers JP, Terpstra OT, Kuppen PJ (2003) The immunological consequences of photodynamic treatment of cancer, a literature review. Immunobiology 207:105-113
28. Jalili A, Makowski M, Switaj T, Nowis D, Wilczynski GM, Wilczek E, Chorazy-Massalska M, Radzikowska A, Maslinski W, Bialy L, Sienko J, Sieron A, Adamek M, Basak G, Mroz P, Krasnodebski IW, Jakobisiak M, Golab J (2004) Effective photoimmunotherapy of murine colon carcinoma induced by the combination of photodynamic therapy and dendritic cells. Clin Cancer Res 10:4498-4508
29. Korbelik M, Sun J, Cecic I (2005) Photodynamic therapy-induced cell surface expression and release of heat shock proteins: Relevance for tumor response. Cancer Res 65:1018-1026